Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis.

Welton T, Maller JJ, Lebel RM, Tan ET, Rowe DB, Grieve SM.

Neuroimage Clin. 2019 Jul 22;24:101953. doi: 10.1016/j.nicl.2019.101953. [Epub ahead of print]

2.

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.

Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-10. doi: 10.1080/21678421.2019.1632899. [Epub ahead of print]

PMID:
31284774
3.

Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression.

Tarr IS, McCann EP, Benyamin B, Peters TJ, Twine NA, Zhang KY, Zhao Q, Zhang ZH, Rowe DB, Nicholson GA, Bauer D, Clark SJ, Blair IP, Williams KL.

Sci Rep. 2019 Jun 4;9(1):8254. doi: 10.1038/s41598-019-44765-4.

4.

Limitations of Electromyography in the Assessment of Abdominal Wall Muscle Contractility Following Botulinum Toxin A Injection.

Tomazini Martins R, Elstner KE, Skulina C, Rodriguez-Acevedo O, Read JW, Rowe DB, Ibrahim N.

Front Surg. 2019 Apr 9;6:16. doi: 10.3389/fsurg.2019.00016. eCollection 2019.

5.

The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling.

Crook A, McEwen A, Fifita JA, Zhang K, Kwok JB, Halliday G, Blair IP, Rowe DB.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):310-316. doi: 10.1080/21678421.2019.1588904. Epub 2019 Mar 23.

PMID:
30907153
6.

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.

Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O'Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM.

Sci Transl Med. 2018 Oct 31;10(465). pii: eaah4066. doi: 10.1126/scitranslmed.aah4066.

PMID:
30381407
7.

COMPLEX-VALUED TIME SERIES MODELING FOR IMPROVED ACTIVATION DETECTION IN FMRI STUDIES.

Adrian DW, Maitra R, Rowe DB.

Ann Appl Stat. 2018 Sep;12(3):1451-1478. doi: 10.1214/17-AOAS1117. Epub 2018 Sep 11.

PMID:
30294404
8.

Impacts of simultaneous multislice acquisition on sensitivity and specificity in fMRI.

Risk BB, Kociuba MC, Rowe DB.

Neuroimage. 2018 May 15;172:538-553. doi: 10.1016/j.neuroimage.2018.01.078. Epub 2018 Feb 3.

PMID:
29408461
9.

Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.

Benyamin B, He J, Zhao Q, Gratten J, Garton F, Leo PJ, Liu Z, Mangelsdorf M, Al-Chalabi A, Anderson L, Butler TJ, Chen L, Chen XD, Cremin K, Deng HW, Devine M, Edson J, Fifita JA, Furlong S, Han YY, Harris J, Henders AK, Jeffree RL, Jin ZB, Li Z, Li T, Li M, Lin Y, Liu X, Marshall M, McCann EP, Mowry BJ, Ngo ST, Pamphlett R, Ran S, Reutens DC, Rowe DB, Sachdev P, Shah S, Song S, Tan LJ, Tang L, van den Berg LH, van Rheenen W, Veldink JH, Wallace RH, Wheeler L, Williams KL, Wu J, Wu X, Yang J, Yue W, Zhang ZH, Zhang D, Noakes PG, Blair IP, Henderson RD, McCombe PA, Visscher PM, Xu H, Bartlett PF, Brown MA, Wray NR, Fan D.

Nat Commun. 2017 Sep 20;8(1):611. doi: 10.1038/s41467-017-00471-1.

10.

Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.

Crook A, Williams K, Adams L, Blair I, Rowe DB.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):475-485. doi: 10.1080/21678421.2017.1332079. Epub 2017 Jun 6. Review.

PMID:
28585888
11.

The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia.

McCann EP, Williams KL, Fifita JA, Tarr IS, O'Connor J, Rowe DB, Nicholson GA, Blair IP.

Clin Genet. 2017 Sep;92(3):259-266. doi: 10.1111/cge.12973. Epub 2017 Mar 30.

PMID:
28105640
12.

Identifying the third dimension in 2D fluoroscopy to create 3D cardiac maps.

Sra J, Krum D, Choudhuri I, Belanger B, Palma M, Brodnick D, Rowe DB.

JCI Insight. 2016 Dec 22;1(21):e90453. doi: 10.1172/jci.insight.90453.

13.

Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.

Zahran S, Laidlaw MA, Rowe DB, Ball AS, Mielke HW.

Environ Res. 2017 Feb;153:181-190. doi: 10.1016/j.envres.2016.11.023. Epub 2016 Dec 18.

PMID:
27992849
14.
15.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, Blokhuis AM, Sproviero W, Jones AR, Kenna KP, van Eijk KR, Harschnitz O, Schellevis RD, Brands WJ, Medic J, Menelaou A, Vajda A, Ticozzi N, Lin K, Rogelj B, Vrabec K, Ravnik-Glavač M, Koritnik B, Zidar J, Leonardis L, Grošelj LD, Millecamps S, Salachas F, Meininger V, de Carvalho M, Pinto S, Mora JS, Rojas-García R, Polak M, Chandran S, Colville S, Swingler R, Morrison KE, Shaw PJ, Hardy J, Orrell RW, Pittman A, Sidle K, Fratta P, Malaspina A, Topp S, Petri S, Abdulla S, Drepper C, Sendtner M, Meyer T, Ophoff RA, Staats KA, Wiedau-Pazos M, Lomen-Hoerth C, Van Deerlin VM, Trojanowski JQ, Elman L, McCluskey L, Basak AN, Tunca C, Hamzeiy H, Parman Y, Meitinger T, Lichtner P, Radivojkov-Blagojevic M, Andres CR, Maurel C, Bensimon G, Landwehrmeyer B, Brice A, Payan CA, Saker-Delye S, Dürr A, Wood NW, Tittmann L, Lieb W, Franke A, Rietschel M, Cichon S, Nöthen MM, Amouyel P, Tzourio C, Dartigues JF, Uitterlinden AG, Rivadeneira F, Estrada K, Hofman A, Curtis C, Blauw HM, van der Kooi AJ, de Visser M, Goris A, Weber M, Shaw CE, Smith BN, Pansarasa O, Cereda C, Del Bo R, Comi GP, D'Alfonso S, Bertolin C, Sorarù G, Mazzini L, Pensato V, Gellera C, Tiloca C, Ratti A, Calvo A, Moglia C, Brunetti M, Arcuti S, Capozzo R, Zecca C, Lunetta C, Penco S, Riva N, Padovani A, Filosto M, Muller B, Stuit RJ; PARALS Registry; SLALOM Group; SLAP Registry; FALS Sequencing Consortium; SLAGEN Consortium; NNIPPS Study Group, Blair I, Zhang K, McCann EP, Fifita JA, Nicholson GA, Rowe DB, Pamphlett R, Kiernan MC, Grosskreutz J, Witte OW, Ringer T, Prell T, Stubendorff B, Kurth I, Hübner CA, Leigh PN, Casale F, Chio A, Beghi E, Pupillo E, Tortelli R, Logroscino G, Powell J, Ludolph AC, Weishaupt JH, Robberecht W, Van Damme P, Franke L, Pers TH, Brown RH, Glass JD, Landers JE, Hardiman O, Andersen PM, Corcia P, Vourc'h P, Silani V, Wray NR, Visscher PM, de Bakker PI, van Es MA, Pasterkamp RJ, Lewis CM, Breen G, Al-Chalabi A, van den Berg LH, Veldink JH.

Nat Genet. 2016 Sep;48(9):1043-8. doi: 10.1038/ng.3622. Epub 2016 Jul 25.

16.

Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.

Lee JM, Tan V, Lovejoy D, Braidy N, Rowe DB, Brew BJ, Guillemin GJ.

Neuropharmacology. 2017 Jan;112(Pt B):346-364. doi: 10.1016/j.neuropharm.2016.05.011. Epub 2016 Jun 3. Review.

PMID:
27265569
17.

Complex-valued time-series correlation increases sensitivity in FMRI analysis.

Kociuba MC, Rowe DB.

Magn Reson Imaging. 2016 Jul;34(6):765-770. doi: 10.1016/j.mri.2016.03.011. Epub 2016 Mar 14.

PMID:
26988705
18.

Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.

Dzamko N, Rowe DB, Halliday GM.

Mov Disord. 2016 Jun;31(6):889-97. doi: 10.1002/mds.26529. Epub 2016 Feb 25.

PMID:
26917005
19.

A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.

Laidlaw MA, Rowe DB, Ball AS, Mielke HW.

Int J Environ Res Public Health. 2015 Dec 19;12(12):16124-35. doi: 10.3390/ijerph121215047.

20.

Separation of parallel encoded complex-valued slices (SPECS) from a single complex-valued aliased coil image.

Rowe DB, Bruce IP, Nencka AS, Hyde JS, Kociuba MC.

Magn Reson Imaging. 2016 Apr;34(3):359-69. doi: 10.1016/j.mri.2015.11.003. Epub 2015 Nov 21.

21.

Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin.

Williams KL, McCann EP, Fifita JA, Zhang K, Duncan EL, Leo PJ, Marshall M, Rowe DB, Nicholson GA, Blair IP.

Neurobiol Aging. 2015 Dec;36(12):3334.e1-3334.e5. doi: 10.1016/j.neurobiolaging.2015.08.013. Epub 2015 Aug 18.

PMID:
26350399
22.

Adult-onset Alexander's disease mimicking degenerative disease.

Ahmad O, Rowe DB.

Pract Neurol. 2015 Oct;15(5):393-5. doi: 10.1136/practneurol-2015-001144. Epub 2015 May 28.

PMID:
26023202
23.

Incorporating relaxivities to more accurately reconstruct MR images.

Karaman M, Bruce IP, Rowe DB.

Magn Reson Imaging. 2015 May;33(4):374-84. doi: 10.1016/j.mri.2015.01.003. Epub 2015 Jan 15.

24.

Personal reflections on James S. Hyde.

Biswal B, Pawela C, Grist T, Meyerand ME, Nencka AS, DeYoe EA, Li SJ, Rowe DB, Kiviniemi V, Cox RW, Bodurka J, Ogawa S, Koretsky A, Hu X, Kim SG.

Brain Connect. 2014 Nov;4(9):631-5. doi: 10.1089/brain.2014.1503. No abstract available.

25.

Quantification of the statistical effects of spatiotemporal processing of nontask FMRI data.

Karaman M, Nencka AS, Bruce IP, Rowe DB.

Brain Connect. 2014 Nov;4(9):649-61. doi: 10.1089/brain.2014.0278. Epub 2014 Sep 19.

26.

Quantifying the statistical impact of GRAPPA in fcMRI data with a real-valued isomorphism.

Bruce IP, Rowe DB.

IEEE Trans Med Imaging. 2014 Feb;33(2):495-503. doi: 10.1109/TMI.2013.2288521. Epub 2013 Nov 6.

PMID:
24235300
27.

A statistical fMRI model for differential T2* contrast incorporating T1 and T2* of gray matter.

Karaman MM, Bruce IP, Rowe DB.

Magn Reson Imaging. 2014 Jan;32(1):9-27. doi: 10.1016/j.mri.2013.09.001. Epub 2013 Oct 3.

PMID:
24183567
28.

Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.

Dzamko N, Chua G, Ranola M, Rowe DB, Halliday GM.

J Parkinsons Dis. 2013;3(2):145-52. doi: 10.3233/JPD-130174.

PMID:
23938344
29.

Ricean over Gaussian modelling in magnitude fMRI Analysis-Added Complexity with Negligible Practical Benefits.

Adrian DW, Maitra R, Rowe DB.

Stat. 2013;2(1):303-316. doi: 10.1002/sta4.34. Epub 2013 Dec 8.

30.

Diffusion-weighted magnetic resonance imaging of the prostate: improved robustness with stretched exponential modeling.

Mazaheri Y, Afaq A, Rowe DB, Lu Y, Shukla-Dave A, Grover J.

J Comput Assist Tomogr. 2012 Nov-Dec;36(6):695-703. doi: 10.1097/RCT.0b013e31826bdbbd.

PMID:
23192207
31.

The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome.

Ha AD, Parratt KL, Rendtorff ND, Lodahl M, Ng K, Rowe DB, Sue CM, Hayes MW, Tranebjaerg L, Fung VS.

Mov Disord. 2012 Jul;27(8):1034-40. doi: 10.1002/mds.25033. Epub 2012 Jun 26.

PMID:
22736418
32.

The SENSE-Isomorphism Theoretical Image Voxel Estimation (SENSE-ITIVE) model for reconstruction and observing statistical properties of reconstruction operators.

Bruce IP, Karaman MM, Rowe DB.

Magn Reson Imaging. 2012 Oct;30(8):1143-66. doi: 10.1016/j.mri.2012.04.002. Epub 2012 May 21.

33.

Physiologic noise regression, motion regression, and TOAST dynamic field correction in complex-valued fMRI time series.

Hahn AD, Rowe DB.

Neuroimage. 2012 Feb 1;59(3):2231-40. doi: 10.1016/j.neuroimage.2011.09.082. Epub 2011 Oct 7.

34.

A statistical examination of SENSE image reconstruction via an isomorphism representation.

Bruce IP, Karaman MM, Rowe DB.

Magn Reson Imaging. 2011 Nov;29(9):1267-87. doi: 10.1016/j.mri.2011.07.016. Epub 2011 Sep 9.

PMID:
21908127
35.

Long-term vascular access ports as a means of sedative administration in a rodent fMRI survival model.

Hettinger PC, Li R, Yan JG, Matloub HS, Cho YR, Pawela CP, Rowe DB, Hyde JS.

J Neurosci Methods. 2011 Sep 15;200(2):106-12. doi: 10.1016/j.jneumeth.2011.06.018. Epub 2011 Jun 24.

36.

Adult onset leucodystrophy with neuroaxonal spheroids and pigmented glia (ALSP): report of a new kindred.

Tan K, Brewer J, Rowe DB, Jenkins B, Powers JM, Buckland ME.

Neuropathol Appl Neurobiol. 2012 Feb;38(1):95-100. doi: 10.1111/j.1365-2990.2011.01173.x. No abstract available.

PMID:
21418267
38.

Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.

Huang Y, Rowe DB, Halliday GM.

J Parkinsons Dis. 2011;1(3):271-6. doi: 10.3233/JPD-2011-11027.

PMID:
23939307
39.

Green roofs as a means of pollution abatement.

Rowe DB.

Environ Pollut. 2011 Aug-Sep;159(8-9):2100-10. doi: 10.1016/j.envpol.2010.10.029. Epub 2010 Nov 13. Review.

PMID:
21074914
40.

Quantitative analysis of arterial spin labeling FMRI data using a general linear model.

Hernandez-Garcia L, Jahanian H, Rowe DB.

Magn Reson Imaging. 2010 Sep;28(7):919-27. doi: 10.1016/j.mri.2010.03.035. Epub 2010 Apr 24.

41.

Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers.

Vucic S, Winhammar JM, Rowe DB, Kiernan MC.

Clin Neurophysiol. 2010 Oct;121(10):1781-5. doi: 10.1016/j.clinph.2010.02.164. Epub 2010 Apr 1.

PMID:
20362497
42.

Regression Models for Identifying Noise Sources in Magnetic Resonance Images.

Zhu H, Li Y, Ibrahim JG, Shi X, An H, Chen Y, Gao W, Lin W, Rowe DB, Peterson BS.

J Am Stat Assoc. 2009 Jun 1;104(486):623-637.

43.

Complex-valued analysis of arterial spin labeling-based functional magnetic resonance imaging signals.

Hernandez-Garcia L, Vazquez AL, Rowe DB.

Magn Reson Med. 2009 Dec;62(6):1597-608. doi: 10.1002/mrm.22106.

44.

Carbon sequestration potential of extensive green roofs.

Getter KL, Rowe DB, Robertson GP, Cregg BM, Andresen JA.

Environ Sci Technol. 2009 Oct 1;43(19):7564-70.

PMID:
19848177
45.

Magnitude and phase signal detection in complex-valued fMRI data.

Rowe DB.

Magn Reson Med. 2009 Nov;62(5):1356-7; author reply 1358-60. doi: 10.1002/mrm.21882. No abstract available.

46.

Functional magnetic resonance imaging brain activation directly from k-space.

Rowe DB, Hahn AD, Nencka AS.

Magn Reson Imaging. 2009 Dec;27(10):1370-81. doi: 10.1016/j.mri.2009.05.048. Epub 2009 Jul 15.

47.

MAgnitude and PHase Thresholding (MAPHT) of noisy complex-valued magnetic resonance images.

Rowe DB, Haacke EM.

Magn Reson Imaging. 2009 Nov;27(9):1271-80. doi: 10.1016/j.mri.2009.05.008. Epub 2009 Jun 23.

48.

A Mathematical Model for Understanding the STatistical effects of k-space (AMMUST-k) preprocessing on observed voxel measurements in fcMRI and fMRI.

Nencka AS, Hahn AD, Rowe DB.

J Neurosci Methods. 2009 Jul 30;181(2):268-82. doi: 10.1016/j.jneumeth.2009.05.007. Epub 2009 May 20.

49.

Anti-melanin antibodies are increased in sera in Parkinson's disease.

Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Riederer P, Gerlach M, Halliday GM.

Exp Neurol. 2009 Jun;217(2):297-301. doi: 10.1016/j.expneurol.2009.03.002. Epub 2009 Mar 13.

PMID:
19289120
50.

Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?

Sutherland GT, Halliday GM, Silburn PA, Mastaglia FL, Rowe DB, Boyle RS, O'Sullivan JD, Ly T, Wilton SD, Mellick GD.

Mov Disord. 2009 Apr 30;24(6):833-8. doi: 10.1002/mds.22214.

PMID:
19224617

Supplemental Content

Support Center